Journal of Addiction Medicine

Article	Citations
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	73
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	53
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	40
Patient Perceptions of Integrating Meditation-based Interventions in Office-based Opioid Treatment with Buprenorphine: A Mixed-methods Survey	37
A Clinical Guide to Support the Implementation of Addiction Consult Services and the Value of Teaching and Technical Assistance	36
The Social Context of Unhealthy Alcohol Use Among Emergency Department Patients: A Cross Sectional Study	34
Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge	32
Twelve-month Treatment Retention and Associated Factors: A Comparison of 2 Medically Assisted Therapy Clinics in Dar es Salaam, Tanzania	32
A Case of Acute Opioid Withdrawal after Liposuction Surgery in a Patient on Extended-release Buprenorphine	30
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	28
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine	25
Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings	24
Commentary on “Application of an Existing Syndromic Surveillance System to Quantify Possible Cases of Opioid-associated Amnestic Syndrome in Massachusetts”	24
The Role of Primary Care in the Initiation of Opioid Use Disorder Treatment in Statewide Public and Private Insurance	23
North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic	22
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation	20
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	20
Evaluation and Management of Buprenorphine Extended-Release Injection Thrombophlebitis: A Case Report	20
Alcohol-related Opioid Overdose Deaths in Minnesota Between 2011 and 2020: Trends by Sex	19
Association of State Drug Laws with Nonmedical Use of Prescription Medications in Adolescents	19
Letter to the Editor (RE: Polles et al)	19
Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-center Observational Study	18
Implementation of a Naloxone Best Practice Advisory Into an Electronic Health Record	18
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	18
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	17

Buprenorphine Monoproduct for Buprenorphine/Naloxone Tolerability Problems: Navigating Stigma for Patient-centered Addiction Care without Guideline Support	17
Hepatitis C Virus Cascade of Care Among Perinatal Patients in Maine Diagnosed With Opioid Use Disorder, 2015–2020	17
Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial	16
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	16
Racial-ethnic Differences in Reasons for Misuse of Prescription Medications Among US Adults	16
Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder	16
Response to the Federation of State Physician Health Program's Commentary	15
Virtual Care in an Outpatient Subspecialty Substance Use Disorder Treatment Program	15
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	15
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	14
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	14
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	14
Statewide Trends in Buprenorphine Prescribing in Rural and Nonrural Vermont: Analysis of Population-based Patient Pharmacy Claims	14
Struggling With Recovery From Opioids: Who Is at Risk During COVID-19?	13
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	12
Is Gastric Bypass a Risk Factor for Complicated Alcohol Withdrawal? Case Report and Literature Review	12
Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department	11
Prescription Drug Misuse with Alcohol Coingestion among US Adolescents: Youth Experiences, Health-related Factors, and Other Substance Use Behaviors	11
Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 – 2020	11
Efficacy of Brief Interventions for Comorbid Substance Misuse in Patients on Opioid Agonist Treatment: A Systematic Review and Meta-analysis	10
Associations of Methadone and BUP/NX Dose Titration Patterns With Retention in Treatment and Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: Secondary Analysis of the OPTIMA Stud	10
Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis	10
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	10
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	10
Blood Oxygenation and Heart Rate Changes After Diamorphine Intravenous Injection During Opioid Agonist Treatment for Outpatients With Heroin Dependence	10
Extended-release Naltrexone Is Not Linked to Hepatotoxicity in Adults Experiencing Homelessness and Alcohol Use Disorder	9
A Nationwide Survey Study of Recovery Community Centers Supporting People in Recovery From Substance Use Disorder	9
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	9
Characterizing Substance Use Disorders Among Transgender Adults Receiving Care at a Large Urban Safety Net Hospital	9
Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a R	9
Use of Video Directly Observed Therapy and Characteristics Associated With Use Among Patients Treated With Buprenorphine in an Office-based Setting	9
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder	9
Withdrawal-like Symptoms in Problematic Pornography Use: A Scoping Review	8
Challenges of Drug Testing in Addiction Treatment	8
An Intervention to Improve Evidence-based Nicotine Prescribing by Primary Care Physicians	8
Response to Martins et al.	8
Low-dose Induction of Buprenorphine in Pregnancy: A Case Series	8
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	8
Off-label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report	8
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	8
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	8
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	8
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	8
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	8
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	7
Menstrual Pain and Substance Use in Women Receiving Inpatient Treatment for Substance Use Disorders	7
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	7
Association of Opioid Use Disorder–Related Service Trajectories during Pregnancy and Postpartum Health Service Use: A Group-Based Multitrajectory Modeling Study	7
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	7
Association Between Buprenorphine Adherence Trajectories, Health Outcomes, and Health Care Costs Among Medicaid Enrollees	7

Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	7
New Alcohol-related Condition Diagnoses Are Associated With Opioid Tapers Among Patients Receiving Long-term Opioid Therapy	7
Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder	7
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	7
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	7
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	7
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	7
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Outcomes of Emergency Department Patients With Opioid Use Disorder Utilizing a Virtual Addiction Bridge Clinic: A Case Series	6
Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report	6
Increased Wound Prevalence in those Exposed to Xylazine and Fentanyl Compared to Those Exposed to Fentanyl: An Observational Study	6
Drug-induced Liver Injury Due to Medications for Alcohol Use Disorder: Results From the DILIN Prospective Study	6
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	6
Global and Regional Burden and Trend of Neoplasms Attributable to Alcohol Consumption in the Past 3 Decades	6
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	6
Malignant Catatonia in the Setting of Acute Methamphetamine and Cocaine Intoxication	6
Longitudinal Associations Between Use of Tobacco and Cannabis Among People Who Smoke Cigarettes in Real-world Smoking Cessation Treatment	6
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes	6
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	6
Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration	6
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	6
Trajectories of Opioid Misuse and Opioid Use Disorder Among Adults With Chronic Pain and HIV: An Observational Study	6
Induction to Methadone 80 mg in the First Week of Treatment of Patients Who Use Fentanyl: A Case Series From an Outpatient Opioid Treatment Program	6
Evaluation of Low-dose Buprenorphine Initiation With Buprenorphine Buccal Films in Hospitalized Patients: A Retrospective Cohort Study	6
Buprenorphine Salivary Gland Accumulation Sustaining High Oral Fluid Exposure and Increasing the Risk of Streptococcus mutans Biofilm Formation	6
Individuals Reporting Past 3-month Smoked Stimulant Use Are Placed at Risk for Infection and Injury Amid COVID-19	6
Kava Withdrawal Treated With Phenobarbital—A Case Report and Literature Review	6
5-Day Injectable Extended-release Buprenorphine Initiation in Non–opioid-tolerant Individuals in a Carceral Setting: A Case Series	5
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	5
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	5
Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada	5
Postpartum Treatment for Chronic Hepatitis C Virus Among People With Opioid Use Disorder: A Prospective Pilot Clinical Trial	5
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	5
Utility of the Global Appraisal of Individual Needs Recommendation and Referral Report for Substance Use Diagnosis, Treatment Planning, and Placement	5
Low-dose Buprenorphine Initiation in an Intubated and Sedated Patient: A Case Report	5
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	5
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	5
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality	5
Use of Practices to Reduce of Sudden Unexpected Infant Death among Caregivers of Opioid Exposed Newborns	5
Racial and Ethnic Inequities in the Receipt of Medications to Treat Opioid Use Disorder Among Pregnant People: A Meta-analysis	5
Buprenorphine Administration and Prescribing at Emergency Departments: A National Analysis from 2014–2021	5
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	5
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder	5
In-hospital Substance Use Policies: An Opportunity to Advance Equity, Reduce Stigma, and Offer Evidence-based Addiction Care	5
Case Series of Individuals Treated With Naltrexone During Pregnancy for Opioid and/or Alcohol Use Disorder	5
Mapping Buprenorphine Access at Philadelphia Pharmacies	5
Acute Alcohol Consumption Reduces Uncertainty Choices	5
Maternal Perspective of Inpatient Methadone Initiation: Opportunities to Increase Retention in Treatment	5
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	5
30-Month Impact of Medications for Opioid Use Disorder on Acute Care Utilization in Rural Communities	5
Under the Skin: The Relationship Between Subcutaneous Injection and Skin Infections Among People Who Inject Drugs	5
Non-medical Mephentermine Use: A Systematic Review of Literature	5
Letter in Reply	4
All a-BORG! The Dangerous Drinking Trend Steamrolling Across Social Media and College Campuses	4
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	4
Prescribe to Save Lives: An Intervention to Increase Naloxone Prescribing Among HIV Clinicians	4
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	4
Trends in Characteristics of Prescription Opioid-related Poisonings among Older Adults in the United States, 2015–2021	4
Harnessing the Power of Social Media to Understand the Impact of COVID-19 on People Who Use Drugs During Lockdown and Social Distancing	4
Gender Differences in Civil Commitment Hearing Experience for Persons Who Use Opioids	4
Perception of Resource Allocations to Address the Opioid Epidemic	4
Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012	4
Exploration Into Patterns of Cannabis Use Across Pregnancy and Postpartum	4
Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting	4
Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis	4
Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial	4
Letter in Reply in Barnes et al	4
Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs	4
Phencyclidine Positivity on Urine Drug Screening in Patients Treated for Alcohol Withdrawal on a Dual-diagnosis Medically Assisted Withdrawal Unit	4
The Other Infodemic: Media Misinformation about Involuntary Commitment for Substance Use	4
Parent Guidance on Alcohol Use for Youth With Chronic Medical Conditions	4
One Fictional Opioid Overdose in Eighteenth-century England and One Attempted Opioid Overdose in Nineteenth-century America	4
Research With Women Who Use Drugs: Applying a Trauma-informed Framework	4
Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study	4
Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial	4
Prevalence and Clinical Significance of Psychiatric Comorbidities With Gambling Disorder in 12 Clinical Settings in Japan	4
Patient Preferences for Mobile Health Applications to Support Recovery	4

Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	4
Associations of Current and Remitted Cannabis Use Disorder With Health-related Quality of Life and Employment Among US Adults	3
A Brief Online Training to Address Pharmacists' Willingness to Dispense Buprenorphine	3
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	3
Federation of State Physician Health Programs' Response to Helping the Helpers	3
Decline in Prenatal Buprenorphine/Naloxone Fills during the COVID-19 Pandemic in the United States	3
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	3
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	3
Letter in Reply	3
Stigma in Large Language Models: A Chatbot Responds	3
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	3
Varenicline for the Treatment of Cocaine Dependence	3
Racial and Ethnic Disparities in Geographic Availability of Buprenorphine	3
Opioid Use Behaviors Among People With Disability in the United States: An Analysis of the National Survey on Drug Use and Health	3
Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments	3
The Need to Rule Out Intranasal Self-administration of Buprenorphine-Naloxone Combinations Before Prescribing Buprenorphine Without Naloxone	3
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	3
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	3
Alignment Between Resident Medical Condition Regard Scale Scores and Desire to Treat Patients With Opioid Use Disorder	3
Longitudinal Associations Between Use of Tobacco and Cannabis Among People Who Smoke Cigarettes in Real-world Smoking Cessation Treatment: Erratum	3
The Howard Street Method: A Community Pharmacy-led Low Dose Overlap Buprenorphine Initiation Protocol for Individuals Using Fentanyl	3
Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration	3
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	3
Association Between Benzodiazepine and Opioid Prescription and Mortality Among Patients in a Large Healthcare System	3
Cannabis Use and Stroke: Does a Risk Exist?	3
Distress Tolerance in the Comorbid Chronic Pain and Opioid Use Disorder Population	3
Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail	3
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	3
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	3
“Meeting Patients Where They're at”: Clinician Perspectives on Integration of Family Planning Services into Office-Based Addiction Treatment	3
Maternal Perception of Infant Sleep and Bonding in Opioid Use Disorder	3
Peer Support Specialists: An Underutilized Resource in the Criminal Justice System for Opioid Use Disorder Management?	3
Polysubstance Use in Adults With Opioid Use Disorder Receiving Buprenorphine Maintenance	3
Buprenorphine-naloxone versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	3
Alcohol Consumption During the First Year of the COVID-19 Pandemic in the United States: Results From a Nationally Representative Longitudinal Survey	3
Findings From Implementing a Patient Experience Survey in a Quality Measurement System for Substance Abuse Disorder Treatment Facilities in 6 States	3
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	3
Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome	3